TP53 and metastatic malignant neoplasm in the lymph nodes: Therefore, despite the high rate of lymph node metastases in p53-mutated Ecs, the exact impact of lymphadenectomy on long-term outcomes is hard to predict, and prospective clinical trials are needed to provide evidence on this issue.